Superstring Capital Management »

Ascendis Pharma A S shares owned by Superstring Capital Management

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Superstring Capital Management from 13F filings

Historical chart of Superstring Capital Management investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Superstring Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Superstring Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 13k 151.17

More positions owned by Superstring Capital Management

Cytokinetics Com New (CYTK)
Nkarta (NKTX)
89bio (ETNB)
Bridgebio Pharma (BBIO)
Savara (SVRA)
Ideaya Biosciences (IDYA)
Fate Therapeutics (FATE)
Day One Biopharmaceuticals I (DAWN)
Roivant Sciences SHS (ROIV)
Ionis Pharmaceuticals (IONS)
Marinus Pharmaceuticals Com New (MRNS)
Cabaletta Bio (CABA)
Urogen Pharma (URGN)
Verona Pharma Sponsored Ads (VRNA)
Aerovate Therapeutics (AVTE)

View all positions for Superstring Capital Management

Top funds holding Ascendis Pharma A S

RA Capital Management
Artisan Partners Limited Partnership
FMR
Westfield Capital Management Company
Henderson Group
venBio Select Advisor
Wellington Management Company
T. Rowe Price Investment Management
Franklin Resources
T. Rowe Price Associates
Massachusetts Financial Services
Sofinnova Ventures
Brown Advisory Holdings Incorporated
Spyglass Capital Management
Alliancebernstein

View all funds holding Ascendis Pharma A S